BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33245043)

  • 1. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
    Batchelor JM; Thomas KS; Akram P; Azad J; Bewley A; Chalmers JR; Cheung ST; Duley L; Eleftheriadou V; Ellis R; Ferguson A; Goulding JM; Haines RH; Hamad H; Ingram JR; Laguda B; Leighton P; Levell N; Makrygeorgou A; Meakin GD; Millington A; Ogboli M; Rajasekaran A; Ravenscroft JC; Rogers A; Sach TH; Santer M; Stainforth J; Tan W; Wahie S; White J; Whitton ME; Williams HC; Wright A; Montgomery AA
    Health Technol Assess; 2020 Nov; 24(64):1-128. PubMed ID: 33245043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
    Thomas KS; Batchelor JM; Akram P; Chalmers JR; Haines RH; Meakin GD; Duley L; Ravenscroft JC; Rogers A; Sach TH; Santer M; Tan W; White J; Whitton ME; Williams HC; Cheung ST; Hamad H; Wright A; Ingram JR; Levell NJ; Goulding JMR; Makrygeorgou A; Bewley A; Ogboli M; Stainforth J; Ferguson A; Laguda B; Wahie S; Ellis R; Azad J; Rajasekaran A; Eleftheriadou V; Montgomery AA;
    Br J Dermatol; 2021 May; 184(5):828-839. PubMed ID: 33006767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial.
    Haines RH; Thomas KS; Montgomery AA; Ravenscroft JC; Akram P; Chalmers JR; Whitham D; Duley L; Eleftheriadou V; Meakin G; Mitchell EJ; White J; Rogers A; Sach T; Santer M; Tan W; Hepburn T; Williams HC; Batchelor J
    BMJ Open; 2018 Apr; 8(4):e018649. PubMed ID: 29615444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).
    Sach TH; Thomas KS; Batchelor JM; Perways A; Chalmers JR; Haines RH; Meakin GD; Duley L; Ravenscroft JC; Rogers A; Santer M; Tan W; White J; Whitton ME; Williams HC; Cheung ST; Hamad H; Wright A; Ingram JR; Levell N; Goulding JMR; Makrygeorgou A; Bewley A; Ogboli M; Stainforth J; Ferguson A; Laguda B; Wahie S; Ellis R; Azad J; Rajasekaran A; Eleftheriadou V; Montgomery AA;
    Br J Dermatol; 2021 May; 184(5):840-848. PubMed ID: 32920824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT.
    Hopewell S; Keene DJ; Heine P; Marian IR; Dritsaki M; Cureton L; Dutton SJ; Dakin H; Carr A; Hamilton W; Hansen Z; Jaggi A; Littlewood C; Barker K; Gray A; Lamb SE
    Health Technol Assess; 2021 Aug; 25(48):1-158. PubMed ID: 34382931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
    Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robot-assisted training compared with an enhanced upper limb therapy programme and with usual care for upper limb functional limitation after stroke: the RATULS three-group RCT.
    Rodgers H; Bosomworth H; Krebs HI; van Wijck F; Howel D; Wilson N; Finch T; Alvarado N; Ternent L; Fernandez-Garcia C; Aird L; Andole S; Cohen DL; Dawson J; Ford GA; Francis R; Hogg S; Hughes N; Price CI; Turner DL; Vale L; Wilkes S; Shaw L
    Health Technol Assess; 2020 Oct; 24(54):1-232. PubMed ID: 33140719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
    Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.
    Kapoor M; Storrar W; Balls L; Brown TP; Mansur A; Hedley E; Jones T; Roberts C; Shirkey B; Dutton S; Luengo-Fernandez R; Little M; Dewey A; Marshall S; Fogg C; Boughton K; Rahman N; Yu LM; Bradding P; Howarth P; Chauhan AJ
    Health Technol Assess; 2019 Jun; 23(29):1-140. PubMed ID: 31232684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(12):1-134. PubMed ID: 33240453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
    Goldstein LH; Robinson EJ; Pilecka I; Perdue I; Mosweu I; Read J; Jordan H; Wilkinson M; Rawlings G; Feehan SJ; Callaghan H; Day E; Purnell J; Baldellou Lopez M; Brockington A; Burness C; Poole NA; Eastwood C; Moore M; Mellers JD; Stone J; Carson A; Medford N; Reuber M; McCrone P; Murray J; Richardson MP; Landau S; Chalder T
    Health Technol Assess; 2021 Jun; 25(43):1-144. PubMed ID: 34196269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatments compared with early structured physiotherapy in secondary care for adults with primary frozen shoulder: the UK FROST three-arm RCT.
    Brealey S; Northgraves M; Kottam L; Keding A; Corbacho B; Goodchild L; Srikesavan C; Rex S; Charalambous CP; Hanchard N; Armstrong A; Brooksbank A; Carr A; Cooper C; Dias J; Donnelly I; Hewitt C; Lamb SE; McDaid C; Richardson G; Rodgers S; Sharp E; Spencer S; Torgerson D; Toye F; Rangan A
    Health Technol Assess; 2020 Dec; 24(71):1-162. PubMed ID: 33292924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT; Webb NJ; Woolley RL; Afentou N; Mehta S; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdiscectomy compared with transforaminal epidural steroid injection for persistent radicular pain caused by prolapsed intervertebral disc: the NERVES RCT.
    Wilby MJ; Best A; Wood E; Burnside G; Bedson E; Short H; Wheatley D; Hill-McManus D; Sharma M; Clark S; Bostock J; Hay S; Baranidharan G; Price C; Mannion R; Hutchinson PJ; Hughes DA; Marson A; Williamson PR
    Health Technol Assess; 2021 Apr; 25(24):1-86. PubMed ID: 33845941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.